FDA Drug Recalls

Recalls / Class II

Class IID-1722-2019

Product

Nitrofurantoin Monohydrate/Macrycrystals Capsules, 100 mg, 100-count bottle, Rx Only, Distributed by: Alvogen, Inc. Pine Brook, NY 07058 USA, NDC 47781-303-01

Brand name
Nitrofurantoin Monohydrate/ Macrocrystalline
Generic name
Nitrofurantoin Monohydrate/macrocrystalline
Active ingredients
Nitrofurantoin, Nitrofurantoin Monohydrate
Route
Oral
NDC
47781-303
FDA application
NDA020064
Affected lot / code info
Lot # 471976, Exp 03/2020

Why it was recalled

Failed dissolution specifications

Recalling firm

Firm
Alvogen, Inc
Manufacturer
Alvogen Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
10 Bloomfield Ave Bldg B Ste 2, N/A, Pine Brook, New Jersey 07058-9743

Distribution

Quantity
2784 bottles
Distribution pattern
Natonwide, PR

Timeline

Recall initiated
2019-07-24
FDA classified
2019-08-12
Posted by FDA
2019-08-21
Terminated
2021-08-04
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1722-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Nitrofurantoin Monohydrate/ Macrocrystalline · FDA Drug Recalls